SMARCA4 alterations in non-small cell lung cancer: a systematic review and meta-analysis

CONCLUSION: Our findings suggest that SMARCA4 mutation negatively affects NSCLC OS and PFS. The prognostic effects of SMARCA4-co-occurring mutations and the predictive role of SMARCA4 mutation status in immunotherapy require further exploration.PMID:38702192 | DOI:10.1136/jcp-2024-209394

Source: Clinical Lung Cancer - May 3, 2024 Category: Cancer & Oncology Authors: Durgesh Wankhede Sandeep Grover Paul Hofman Source Type: research